Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis
- PMID: 30376437
- DOI: 10.1177/0961203318805849
Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis
Abstract
Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, the pathogenesis of which remains elusive. The deficiency or excess of thyroid hormone is defined as thyroid dysfunction, including (subclinical) hypothyroidism and (subclinical) hyperthyroidism. Autoimmune factors are likely to be relevant to the development of SLE and thyroid dysfunction. Recently, many studies have indicated that the prevalence of thyroid dysfunction is higher in SLE patients than in the general population. The objective of our study was to perform a systematic review and meta-analysis to find out the relationship between SLE and thyroid dysfunction.
Methods: Literature databases were searched, including PubMed, Embase, Web of science, Cochrane, CNKI, CHINESE WANFANG, China Science and Technology Database (VIP). Studies comparing presence of thyroid dysfunction in SLE patients to healthy controls were extracted. All the statistical analyses were performed with STATA 12.0 software.
Results: Ten studies with 10,500 SLE patients and 44,170 healthy controls were included in this study. The meta-analysis results showed that the prevalence of (subclinical) hypothyroidism in SLE patients was higher than in the healthy controls (hypothyroidism: OR = 2.93, 95% CI = 1.81-4.75; subclinical hypothyroidism: OR = 5.67, 95% CI = 3.50-9.18). No statistical difference of (subclinical) hyperthyroidism was found between SLE patients and controls.
Conclusion: Our meta-analysis suggests that SLE is significantly associated with increased risk of (subclinical) hypothyroidism, but it has little influence on (subclinical) hyperthyroidism.
Keywords: Hyperthyroidism; hypothyroidism; meta-analysis; systemic lupus erythematosus.
Similar articles
-
Systemic lupus erythematosus and thyroid disease: A 10-year study.J Microbiol Immunol Infect. 2015 Dec;48(6):676-83. doi: 10.1016/j.jmii.2014.03.004. Epub 2014 May 26. J Microbiol Immunol Infect. 2015. PMID: 24874431
-
The spectrum of thyroid disorders in systemic lupus erythematosus.Rheumatol Int. 2012 Jan;32(1):73-8. doi: 10.1007/s00296-010-1556-5. Epub 2010 Jul 25. Rheumatol Int. 2012. PMID: 20658291
-
Thyroid Disease and Systemic Lupus Erythematosus.Medicina (Kaunas). 2023 Oct 29;59(11):1911. doi: 10.3390/medicina59111911. Medicina (Kaunas). 2023. PMID: 38003960 Free PMC article.
-
Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction.BMC Cardiovasc Disord. 2019 Apr 4;19(1):83. doi: 10.1186/s12872-019-1055-x. BMC Cardiovasc Disord. 2019. PMID: 30947691 Free PMC article. Review.
-
Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.Ann Palliat Med. 2020 Mar;9(2):207-215. doi: 10.21037/apm.2020.02.11. Epub 2020 Mar 3. Ann Palliat Med. 2020. PMID: 32156138 Review.
Cited by
-
Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism.BMC Med Res Methodol. 2020 May 1;20(1):99. doi: 10.1186/s12874-020-00989-x. BMC Med Res Methodol. 2020. PMID: 32357838 Free PMC article.
-
Dysregulated thyroid hormones correlate with anxiety and depression risk in patients with autoimmune disease.J Clin Lab Anal. 2021 Jan;35(1):e23573. doi: 10.1002/jcla.23573. Epub 2020 Nov 18. J Clin Lab Anal. 2021. PMID: 33210405 Free PMC article.
-
Thyroid Disease in Lupus: An Updated Review.ACR Open Rheumatol. 2020 Feb;2(2):74-78. doi: 10.1002/acr2.11105. Epub 2020 Jan 6. ACR Open Rheumatol. 2020. PMID: 32043833 Free PMC article. Review.
-
Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis.Medicine (Baltimore). 2020 Nov 20;99(47):e23218. doi: 10.1097/MD.0000000000023218. Medicine (Baltimore). 2020. PMID: 33217834 Free PMC article.
-
Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.J Endocrinol Invest. 2023 Apr;46(4):643-665. doi: 10.1007/s40618-022-01994-1. Epub 2023 Jan 7. J Endocrinol Invest. 2023. PMID: 36609775 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical